These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 23588311)

  • 21. Role of Hepatic Drug Transporters in Drug Development.
    Liu H; Sahi J
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S11-22. PubMed ID: 27385168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Research Methods and New Advances in Drug-Drug Interactions Mediated by Renal Transporters.
    Lin K; Kong X; Tao X; Zhai X; Lv L; Dong D; Yang S; Zhu Y
    Molecules; 2023 Jul; 28(13):. PubMed ID: 37446913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity.
    Alim K; Bruyère A; Lescoat A; Jouan E; Lecureur V; Le Vée M; Fardel O
    Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):259-271. PubMed ID: 33292029
    [No Abstract]   [Full Text] [Related]  

  • 24. Emerging transporters of clinical importance: an update from the International Transporter Consortium.
    Hillgren KM; Keppler D; Zur AA; Giacomini KM; Stieger B; Cass CE; Zhang L;
    Clin Pharmacol Ther; 2013 Jul; 94(1):52-63. PubMed ID: 23588305
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transporter-enzyme interplay and the hepatic drug clearance: what have we learned so far?
    Alluri RV; Li R; Varma MVS
    Expert Opin Drug Metab Toxicol; 2020 May; 16(5):387-401. PubMed ID: 32228316
    [No Abstract]   [Full Text] [Related]  

  • 26. Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature.
    Rodrigues AD; Rowland A
    J Pharmacol Exp Ther; 2020 Mar; 372(3):308-319. PubMed ID: 31879375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Utility of Quantitative Proteomics for Enhancing the Predictive Ability of Physiologically Based Pharmacokinetic Models Across Disease States.
    Sharma S; Suresh Ahire D; Prasad B
    J Clin Pharmacol; 2020 Oct; 60 Suppl 1():S17-S35. PubMed ID: 33205430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of Drug Transporters on Pharmacological Responses and Safety.
    Liu CX; Yi XL; Fan HR; Wu WD; Zhang X; Xiao XF; He X
    Curr Drug Metab; 2015; 16(9):732-52. PubMed ID: 26630905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug transporters in pharmacokinetics.
    Petzinger E; Geyer J
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Mar; 372(6):465-75. PubMed ID: 16532306
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Modeling of Drug-Transporter Interactions-An International Transporter Consortium Perspective.
    Schlessinger A; Welch MA; van Vlijmen H; Korzekwa K; Swaan PW; Matsson P
    Clin Pharmacol Ther; 2018 Nov; 104(5):818-835. PubMed ID: 29981151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dealing with the complex drug-drug interactions: towards mechanistic models.
    Varma MV; Pang KS; Isoherranen N; Zhao P
    Biopharm Drug Dispos; 2015 Mar; 36(2):71-92. PubMed ID: 25545151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recent progresses in the experimental methods and evaluation strategies of transporter functions for the prediction of the pharmacokinetics in humans.
    Kitamura S; Maeda K; Sugiyama Y
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Jun; 377(4-6):617-28. PubMed ID: 18536908
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-factorial pharmacokinetic interactions: unraveling complexities in precision drug therapy.
    Bechtold B; Clarke J
    Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):397-412. PubMed ID: 33339463
    [No Abstract]   [Full Text] [Related]  

  • 34. Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites.
    Patel M; Taskar KS; Zamek-Gliszczynski MJ
    J Clin Pharmacol; 2016 Jul; 56 Suppl 7():S23-39. PubMed ID: 27385177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transporter-mediated drug-drug interaction in renal and hepatic elimination processes].
    Nagai J
    Nihon Yakurigaku Zasshi; 2010 Jan; 135(1):34-7. PubMed ID: 20075569
    [No Abstract]   [Full Text] [Related]  

  • 36. Transporter-mediated tissue targeting of therapeutic molecules in drug discovery.
    Zhou J; Xu J; Huang Z; Wang M
    Bioorg Med Chem Lett; 2015 Mar; 25(5):993-7. PubMed ID: 25650254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging in vitro tools to evaluate cytochrome P450 and transporter-mediated drug-drug interactions.
    Lu C; Liao M; Cohen L; Xia CQ
    Curr Drug Discov Technol; 2010 Sep; 7(3):199-222. PubMed ID: 20843292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Navigating Transporter Sciences in Pharmacokinetics Characterization Using the Extended Clearance Classification System.
    El-Kattan AF; Varma MVS
    Drug Metab Dispos; 2018 May; 46(5):729-739. PubMed ID: 29496721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Ontogeny of Drug Transporters: Review and Recommendations of the Pediatric Transporter Working Group.
    Brouwer KL; Aleksunes LM; Brandys B; Giacoia GP; Knipp G; Lukacova V; Meibohm B; Nigam SK; Rieder M; de Wildt SN;
    Clin Pharmacol Ther; 2015 Sep; 98(3):266-87. PubMed ID: 26088472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease-Associated Changes in Drug Transporters May Impact the Pharmacokinetics and/or Toxicity of Drugs: A White Paper From the International Transporter Consortium.
    Evers R; Piquette-Miller M; Polli JW; Russel FGM; Sprowl JA; Tohyama K; Ware JA; de Wildt SN; Xie W; Brouwer KLR;
    Clin Pharmacol Ther; 2018 Nov; 104(5):900-915. PubMed ID: 29756222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.